Joachim Blanz

1.3k total citations
31 papers, 967 citations indexed

About

Joachim Blanz is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Joachim Blanz has authored 31 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in Joachim Blanz's work include Cancer Treatment and Pharmacology (6 papers), Synthesis and biological activity (4 papers) and Quinazolinone synthesis and applications (4 papers). Joachim Blanz is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Synthesis and biological activity (4 papers) and Quinazolinone synthesis and applications (4 papers). Joachim Blanz collaborates with scholars based in Germany, Switzerland and United States. Joachim Blanz's co-authors include Gerhard Ehninger, Klaus‐Peter Zeller, Barbara Proksch, Mark Knapp, Pascal Furet, Reiner Aichholz, Ulrich S. Schuler, Patricia Imbach‐Weese, Christine Fritsch and Giorgio Caravatti and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Pure and Applied Chemistry.

In The Last Decade

Joachim Blanz

30 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joachim Blanz Germany 14 536 202 183 152 123 31 967
Ravi S. Harapanhalli United States 16 410 0.8× 204 1.0× 127 0.7× 162 1.1× 231 1.9× 27 1.1k
Susan M. Ludeman United States 20 593 1.1× 387 1.9× 193 1.1× 128 0.8× 162 1.3× 51 1.4k
Michael A. Shirley United States 15 684 1.3× 204 1.0× 172 0.9× 79 0.5× 230 1.9× 22 1.1k
Robert A. Galemmo United States 19 494 0.9× 158 0.8× 262 1.4× 70 0.5× 143 1.2× 46 1.0k
Richard M. Keenan United States 23 576 1.1× 175 0.9× 394 2.2× 52 0.3× 167 1.4× 39 1.4k
Timothy P. Heffron United States 14 322 0.6× 200 1.0× 297 1.6× 123 0.8× 45 0.4× 21 808
Lois M. Hinman United States 15 664 1.2× 551 2.7× 141 0.8× 82 0.5× 160 1.3× 30 1.6k
Xavier Billot Canada 7 463 0.9× 152 0.8× 144 0.8× 71 0.5× 57 0.5× 10 769
Philip Lienau Germany 21 766 1.4× 468 2.3× 433 2.4× 79 0.5× 43 0.3× 37 1.4k
Robert B. Brundrett United States 18 509 0.9× 348 1.7× 123 0.7× 166 1.1× 379 3.1× 27 1.5k

Countries citing papers authored by Joachim Blanz

Since Specialization
Citations

This map shows the geographic impact of Joachim Blanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Blanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Blanz more than expected).

Fields of papers citing papers by Joachim Blanz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Blanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Blanz. The network helps show where Joachim Blanz may publish in the future.

Co-authorship network of co-authors of Joachim Blanz

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Blanz. A scholar is included among the top collaborators of Joachim Blanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Blanz. Joachim Blanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiang-Wei, Michael Kiffe, Markus Walles, et al.. (2021). Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment. Xenobiotica. 52(1). 65–78. 7 indexed citations
2.
Hoegenauer, Klemens, Nicolas Soldermann, Frédéric J. Zécri, et al.. (2017). Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. ACS Medicinal Chemistry Letters. 8(9). 975–980. 84 indexed citations
3.
Fairhurst, Robin A., Giorgio Caravatti, Vito Guagnano, et al.. (2016). Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(19). 4729–4734. 1 indexed citations
4.
Hoegenauer, Klemens, Nicolas Soldermann, Frédéric Stauffer, et al.. (2016). Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. ACS Medicinal Chemistry Letters. 7(8). 762–767. 49 indexed citations
5.
6.
Thoma, Gebhard, Siem J. Veenstra, Joachim Blanz, et al.. (2015). Orally bioavailable Syk inhibitors with activity in a rat PK/PD model. Bioorganic & Medicinal Chemistry Letters. 25(20). 4642–4647. 6 indexed citations
7.
Fairhurst, Robin A., Marc Gerspacher, Patricia Imbach‐Weese, et al.. (2015). Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3575–3581. 15 indexed citations
8.
Thoma, Gebhard, Alexander B. Smith, Maurice J. van Eis, et al.. (2015). Discovery and Profiling of a Selective and Efficacious Syk Inhibitor. Journal of Medicinal Chemistry. 58(4). 1950–1963. 19 indexed citations
9.
Thoma, Gebhard, Joachim Blanz, Peter Bühlmayer, et al.. (2014). Syk inhibitors with high potency in presence of blood. Bioorganic & Medicinal Chemistry Letters. 24(10). 2278–2282. 17 indexed citations
10.
Furet, Pascal, Vito Guagnano, Robin A. Fairhurst, et al.. (2013). Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorganic & Medicinal Chemistry Letters. 23(13). 3741–3748. 350 indexed citations
11.
Hintermann, Samuel, Konstanze Hurth, Joachim Nozulak, et al.. (2010). Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor. Bioorganic & Medicinal Chemistry Letters. 21(5). 1523–1526. 5 indexed citations
12.
Carcache, David A., Ivo Vranesic, Joachim Blanz, et al.. (2010). Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile. ACS Medicinal Chemistry Letters. 2(1). 58–62. 7 indexed citations
13.
Schuler, Ulrich S., et al.. (1994). Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?. PubMed. 14(5). 759–65. 77 indexed citations
14.
Blanz, Joachim, et al.. (1994). Synthesis and structural elucidation of biliary excreted thioether derivatives of mitoxantrone. Xenobiotica. 24(3). 199–213. 7 indexed citations
15.
Proksch, Barbara, Joachim Blanz, Klaus‐Peter Zeller, & G. Ehninger. (1994). Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 658(2). 349–353. 4 indexed citations
16.
Blanz, Joachim, et al.. (1993). Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates.. PubMed. 53(21). 5135–42. 57 indexed citations
17.
Ehninger, Gerhard, Ulrich S. Schuler, Barbara Proksch, Klaus‐Peter Zeller, & Joachim Blanz. (1990). Pharmacokinetics and Metabolism of Mitoxantrone. Clinical Pharmacokinetics. 18(5). 365–380. 96 indexed citations
18.
Blanz, Joachim, et al.. (1990). Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis. Journal of Chromatography B Biomedical Sciences and Applications. 532(2). 429–437. 28 indexed citations
19.
Blanz, Joachim, et al.. (1989). The isolation and identification of indigo and indirubin from urine of a patient with leukemia.. PubMed. 64(1). 145–56. 8 indexed citations
20.
Blanz, Joachim & Klaus‐Peter Zeller. (1989). 13C‐Markierung der Seitenketten von Mitoxantrone. Journal of Labelled Compounds and Radiopharmaceuticals. 27(1). 91–101. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravi S. Harapanhalli Breakdown of academic impact, for papers by Susan M. Ludeman Breakdown of academic impact, for papers by Michael A. Shirley Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Richard M. Keenan Breakdown of academic impact, for papers by Timothy P. Heffron Breakdown of academic impact, for papers by Lois M. Hinman Breakdown of academic impact, for papers by Xavier Billot Breakdown of academic impact, for papers by Philip Lienau Breakdown of academic impact, for papers by Robert B. Brundrett
Rankless by CCL
2026